Patients who have taken the drug Actos for more than a year to help control type 2 diabetes may be at a a greater risk for developing bladder cancer, according to an increasing volume of research. In August, the Food and Drug Administration (FDA) required Takeda, the manufacturer of Actos, to include a new warning stating that patients who use Actos for longer than 12 months may face an increased risk for bladder cancer. Actos has also been linked to diabetic macular edema and heart failure, among other potential complications. The Alabama defective drug attorneys at Long & Long are currently evaluating potential claims from patients who believe they suffered the ill effects of Actos prescriptions. If you develop bladder cancer after taking Actos, we may be able to help you recover compensation including money for medical expenses, lost wages, and pain and suffering. Research from a number of studies—including those performed by the FDA and European pharmaceutical regulators—indicates that Actos patients may face a 40 percent greater risk of contracting bladder cancer. If you suspect you developed bladder cancer as a result of Actos, please contact the Mobile, Alabama, product liability attorneys at Long & Long for your free case evaluation.